Re-suturing after primary endoscopic sleeve gastroplasty (ESG) for obesity
- PMID: 32583068
- DOI: 10.1007/s00464-020-07666-6
Re-suturing after primary endoscopic sleeve gastroplasty (ESG) for obesity
Abstract
Introduction: Although primary endoscopic sleeve gastroplasty (P-ESG) is effective, some patients may require revision procedures to augment weight loss. We hypothesized that a non-surgical approach using redo ESG (R-ESG) might be a viable option in such patients. We aimed to assess the safety and efficacy of R-ESG following P-ESG to treat obesity.
Methods: We reviewed the outcome of patients who underwent R-ESG at our unit. We classified them as weight loss failure (WF)-< 10% total body weight (TBWL) at 6-months; weight regain (WR)-lost ≥ 10% TBWL and regained 50% of the maximum weight loss at or after 1-year; weight plateau (WP)-lost ≥ 10% TBWL but could not lose further over 3-months. We analyzed the feasibility, safety, and evaluated the efficacy of R-ESG in each group.
Results: Of the 482 patients who underwent P-ESG, 35 (7%) required R- ESG (WF-12, WR-12, WP-11). The mean age, weight, BMI (38.2 kg/m2), and the number of sutures used during P-ESG were similar between the groups. The nadir %TBWL was lowest in WF group compared to WR and WP (6.5% vs. 20% vs. 22.4%, p = 0.001). The mean BMI at R-ESG was 33.6 kg/m2. The time to R-ESG was longer in the WR group compared to WF and WP (22.3 vs. 13.4 vs. 13.7 months, p = 0.03). We placed a median of 3 (range 2-6) sutures. R-ESG was technically successful, and no serious complications occurred. All except two patients were discharged on the same day. The overall %TBWL achieved by R-ESG was significantly higher in WP (26%) as compared to WF (11.2%) and WR (12%), respectively (p = 0.001).
Conclusion: The need for R-ESG after P-ESG is low. R-ESG is safe and induced weight loss in all patients. The maximum benefit was observed in WP.
Keywords: Bariatric endoscopy; Endoscopic sleeve gastroplasty; Obesity; Re-suturing; Weight regain.
Similar articles
-
Endoscopic sleeve gastroplasty (ESG) for morbid obesity: how effective is it?Surg Endosc. 2022 Jan;36(1):352-360. doi: 10.1007/s00464-021-08289-1. Epub 2021 Jan 25. Surg Endosc. 2022. PMID: 33492503
-
Endoscopic Sleeve Gastroplasty (ESG) Is a Reproducible and Effective Endoscopic Bariatric Therapy Suitable for Widespread Clinical Adoption: a Large, International Multicenter Study.Obes Surg. 2018 Jul;28(7):1812-1821. doi: 10.1007/s11695-018-3135-x. Obes Surg. 2018. PMID: 29450845
-
Revisional endoscopic sleeve gastroplasty of laparoscopic sleeve gastrectomy: an international, multicenter study.Gastrointest Endosc. 2021 Jan;93(1):122-130. doi: 10.1016/j.gie.2020.05.028. Epub 2020 May 27. Gastrointest Endosc. 2021. PMID: 32473252
-
IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management.Obes Surg. 2024 Dec;34(12):4318-4348. doi: 10.1007/s11695-024-07510-z. Epub 2024 Nov 1. Obes Surg. 2024. PMID: 39482444 Free PMC article.
-
Endoscopic management of obesity: Impact of endoscopic sleeve gastroplasty on weight loss and co-morbidities at six months and one year.J Visc Surg. 2023 Apr;160(2S):S38-S46. doi: 10.1016/j.jviscsurg.2022.12.003. Epub 2023 Jan 30. J Visc Surg. 2023. PMID: 36725451 Review.
Cited by
-
Advances in endobariatrics: past, present, and future.Gastroenterol Rep (Oxf). 2023 Jul 21;11:goad043. doi: 10.1093/gastro/goad043. eCollection 2023. Gastroenterol Rep (Oxf). 2023. PMID: 37483864 Free PMC article. Review.
-
Division of a long-term symptomatic tissue bridge for reversal of endoscopic sleeve gastroplasty.VideoGIE. 2021 Nov 12;7(2):58-60. doi: 10.1016/j.vgie.2021.10.008. eCollection 2022 Feb. VideoGIE. 2021. PMID: 35146225 Free PMC article.
-
Endoscopic sleeve gastroplasty (ESG) for morbid obesity: how effective is it?Surg Endosc. 2022 Jan;36(1):352-360. doi: 10.1007/s00464-021-08289-1. Epub 2021 Jan 25. Surg Endosc. 2022. PMID: 33492503
-
Endoscopic Sleeve Gastroplasty: A Retrospective Cohort Study of 90 Patients in Colombia.Obes Surg. 2025 Jul;35(7):2706-2710. doi: 10.1007/s11695-025-07945-y. Epub 2025 May 29. Obes Surg. 2025. PMID: 40442462
-
Success Predictors of Endoscopic Sleeve Gastroplasty.Obes Surg. 2024 May;34(5):1496-1504. doi: 10.1007/s11695-024-07109-4. Epub 2024 Mar 7. Obes Surg. 2024. PMID: 38451369 Free PMC article.
References
-
- Caterson ID, Alfadda AA, Auerbach P et al (2019) Gaps to bridge: Misalignment between perception, reality and actions in obesity. Diabetes Obes Metab 21:1914–1924 - DOI
-
- Joseph MS, Konerman MA, Zhang M et al (2018) Long-term outcomes following completion of a structured nutrition and exercise lifestyle intervention program for patients with metabolic syndrome. Diabetes Metab Syndr Obes 11:753–759 - DOI
-
- Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308:2489–2496 - DOI
-
- Look AHEAD Research Group (2014) Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) 22:5–13 - DOI
-
- Buchwald H, Oien DM (2011) Metabolic/bariatric surgery worldwide. Obes Surg 23:427–436 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources